Dalia Haydar, Pharm.D., Ph.D.

  • Research Faculty
  • Principal Investigator, Program for Cell Enhancement and Technologies for Immunotherapies (CETI)
    • Postdoctoral Fellowship Program, Bone Marrow Transplantation and Cell Therapy, St. Jude Children's Research Hospital, Memphis, TN (2022)
    • Ph.D., Pharmaceutical Sciences, University of Kentucky, Lexington, KY (2018)
    • Pharm.D., Pharmacy, Lebanese American University, Byblos, Lebanon (2013)
  • Dalia Haydar, Pharm.D., Ph.D., is an assistant professor of Pediatrics at the George Washington University School of Medicine and Health Sciences. She is also a research faculty at the Center for Cancer and Immunology Research at Children's National Hospital, where she leads efforts for developing CAR T cell immunotherapy for pediatric brain tumors. Dr. Haydar's primary interest is understanding host factors that limit responses to adoptive immunotherapies. Using mechanistic investigations and cutting-edge technologies, Dr. Haydar is trying to develop next-generation cellular immunotherapies that would advance outcomes in pediatric patients with brain tumors.